RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: polycystic ovary syndrome
Accession: DOID:11612
browse the term
Definition: An ovarian dysfunction that is characterized by hyperandrogenism, polycystic ovaries, hirsutism, oligomenorrhea or amenorrhea, anovulation and excessive body weight. (DO)
Synonyms: exact_synonym: Multicystic ovaries; PCO; PCO1; PCOS; PCOS1; Polycystic Ovarian Syndrome; Polycystic Ovarian disease; Polycystic Ovary Syndrome 1; Polycystic ovaries; Sclerocystic Ovarian Degeneration; Sclerocystic Ovaries; Sclerocystic Ovary; Sclerocystic Ovary Syndrome; Stein Leventhal syndrome; Stein-Leventhal synd.; hyperandrogenemia; polycystic ovary
related_synonym: POLYCYSTIC OVARY SYNDROME, SUSCEPTIBILITY TO
primary_id: MESH:D011085
alt_id: MIM:184700
xref: EFO:0000660 ; ICD10CM:E28.2 ; ICD9CM:256.4 ; NCI:C26862 ; NCI:C92847
For additional species annotation, visit the
Alliance of Genome Resources .
G
ABCB6
ATP binding cassette subfamily B member 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr15:121,246,180...121,254,350
Ensembl chr15:121,246,187...121,254,331
G
ADAMTS7
ADAM metallopeptidase with thrombospondin type 1 motif 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 7:47,919,398...47,994,528
Ensembl chr 7:47,929,033...47,994,453
G
ADARB1
adenosine deaminase RNA specific B1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr13:207,746,915...207,791,809
Ensembl chr13:207,691,174...207,791,802
G
ADGRD2
adhesion G protein-coupled receptor D2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 1:265,258,847...265,275,288
Ensembl chr 1:265,259,617...265,275,248
G
ADIPOQ
adiponectin, C1Q and collagen domain containing
ISO
RGD
PMID:16868149
RGD:8694433
NCBI chr13:124,633,906...124,646,237
Ensembl chr13:124,633,685...124,646,646
G
ADM
adrenomedullin
ISO
CTD Direct Evidence: therapeutic
CTD
PMID:33491863
NCBI chr 2:49,229,223...49,231,521
Ensembl chr 2:49,229,223...49,231,866
G
ADRA1A
adrenoceptor alpha 1A
ISO
mRNA,protein:increased expression:ovary
RGD
PMID:15795180
RGD:5508374
NCBI chr14:10,623,391...10,733,378
Ensembl chr14:10,626,293...10,733,068
G
ADRA1B
adrenoceptor alpha 1B
ISO
mRNA,protein:increased expression:ovary
RGD
PMID:15795180
RGD:5508374
NCBI chr16:63,550,123...64,010,838
Ensembl chr16:63,550,130...63,603,034
G
ADRA1D
adrenoceptor alpha 1D
ISO
mRNA,protein:increased expression:ovary
RGD
PMID:15795180
RGD:5508374
NCBI chr17:31,517,021...31,537,361
Ensembl chr17:31,517,021...31,538,362
G
ADRB2
adrenoceptor beta 2
ISO
mRNA,protein:decreased expression:ovary
RGD
PMID:15795180
RGD:5508374
NCBI chr 2:150,032,649...150,035,591
Ensembl chr 2:150,033,579...150,040,731
G
ADRB3
adrenoceptor beta 3
ISO
mRNA:increased expression:gastrointestinal system mesentery, adipose tissue
RGD
PMID:19158405
RGD:2313167
NCBI chr15:48,468,803...48,478,370
Ensembl chr15:48,475,144...48,479,562
G
AKR1C1
aldo-keto reductase family 1, member C1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:16263811 PMID:21262361 PMID:22381227
NCBI chr10:65,580,297...65,594,998
Ensembl chr10:65,576,464...65,678,248
G
AKR1C3
aldo-keto reductase family 1 member C3
ISO
RGD
PMID:8402388
RGD:11541125
NCBI chr10:65,650,223...65,679,878
Ensembl chr10:65,576,464...65,678,248
G
AKT2
AKT serine/threonine kinase 2
ISO
OMIM:184700
MouseDO
NCBI chr 6:48,555,785...48,620,472
Ensembl chr 6:48,555,795...48,587,919
G
AMH
anti-Mullerian hormone
ISO
protein:increased expression:serum
RGD
PMID:17224152
RGD:1601181
NCBI chr 2:76,415,564...76,418,315
Ensembl chr 2:76,414,427...76,418,312
G
ANLN
anillin, actin binding protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr18:37,647,952...37,710,939
Ensembl chr18:37,647,961...37,708,575
G
AR
androgen receptor
no_association
ISO
RGD
PMID:15950642
RGD:1578688
NCBI chr X:53,609,113...53,806,778
Ensembl chr X:53,609,176...53,800,677
G
ARHGAP23
Rho GTPase activating protein 23
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr12:23,581,698...23,667,939
Ensembl chr12:23,581,843...23,667,926
G
ARHGAP30
Rho GTPase activating protein 30
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 4:89,375,486...89,394,190
Ensembl chr 4:89,375,526...89,394,244
G
ASPM
assembly factor for spindle microtubules
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr10:19,971,516...20,039,680
Ensembl chr10:19,975,192...20,039,623
G
ATF1
activating transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 5:16,619,130...16,681,391
Ensembl chr 5:16,618,623...16,681,686
G
ATP5F1B
ATP synthase F1 subunit beta
ISO
mRNA, protein:decreased expression:pancreas (rat)
RGD
PMID:28397049
RGD:13703107
NCBI chr 5:21,984,750...21,992,393
Ensembl chr 5:21,984,580...21,992,407
G
AZGP1
alpha-2-glycoprotein 1, zinc-binding
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 3:7,867,521...7,874,857
G
BAX
BCL2 associated X, apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21062263
NCBI chr 6:54,222,341...54,228,150
Ensembl chr 6:54,222,336...54,228,147
G
BBOF1
basal body orientation factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 7:97,316,630...97,367,526
Ensembl chr 7:97,316,711...97,368,049
G
BCL11A
BCL11 transcription factor A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 3:81,195,217...81,296,165
Ensembl chr 3:81,196,294...81,296,382
G
BCL2
BCL2 apoptosis regulator
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:ovary
CTD RGD
PMID:21062263
RGD:10054496
NCBI chr 1:158,337,403...158,518,214
Ensembl chr 1:158,337,522...158,518,879
G
BLOC1S3
biogenesis of lysosomal organelles complex 1 subunit 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:51,590,497...51,591,222
Ensembl chr 6:51,590,497...51,591,222
G
BMP15
bone morphogenetic protein 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22825968
NCBI chr X:44,613,122...44,620,575
Ensembl chr X:44,613,122...44,620,575
G
CAMK2D
calcium/calmodulin dependent protein kinase II delta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 8:108,916,019...109,221,317
Ensembl chr 8:108,915,572...109,222,905
G
CAPN10
calpain 10
ISO
ClinVar Annotator: match by term: Polycystic ovary syndrome, susceptibility to
ClinVar
PMID:11017071 PMID:11481585 PMID:12161543 PMID:14574648 PMID:14602801
NCBI chr15:139,557,643...139,568,764
Ensembl chr15:139,557,469...139,568,767
G
CARMIL3
capping protein regulator and myosin 1 linker 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 7:75,222,528...75,241,243
Ensembl chr 7:75,222,521...75,241,277
G
CCNB1
cyclin B1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr16:47,338,239...47,348,385
Ensembl chr16:47,338,110...47,348,377
G
CCNE2
cyclin E2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 4:41,802,090...41,821,870
Ensembl chr 4:41,804,377...41,821,874
G
CD36
CD36 molecule
ISO
protein:decreased expression:cardiac muscle cell
RGD
PMID:25702158
RGD:11041149
NCBI chr 9:99,685,748...99,782,296
Ensembl chr 9:99,605,181...99,782,105
G
CDC6
cell division cycle 6
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr12:22,101,281...22,118,441
Ensembl chr12:22,101,282...22,118,593
G
CDH15
cadherin 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:636,350...652,260
Ensembl chr 6:636,377...652,165
G
CEP55
centrosomal protein 55
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr14:104,957,256...104,980,690
Ensembl chr14:104,957,311...104,980,689
G
CIMAP1B
ciliary microtubule associated protein 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 5:215,972...217,973
Ensembl chr 5:215,967...217,974
G
CKS2
CDC28 protein kinase regulatory subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr14:904,762...910,292
Ensembl chr14:904,809...910,289
G
CLDN4
claudin 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 3:11,039,711...11,053,930
Ensembl chr 3:11,039,706...11,053,925
G
CMTR2
cap methyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:14,325,869...14,334,043
Ensembl chr 6:14,323,981...14,334,008
G
CNTROB
centrobin, centriole duplication and spindle assembly protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr12:53,181,096...53,201,670
Ensembl chr12:53,181,642...53,201,667
G
COMT
catechol-O-methyltransferase
ISO
protein:increased expression:ovary
RGD
PMID:17535988
RGD:2289711
NCBI chr14:51,384,729...51,403,997
Ensembl chr14:51,385,738...51,403,998
G
CYP17A1
cytochrome P450 family 17 subfamily A member 1
ISO
protein:increased activity:ovary follicle, theca cell (human)
RGD
PMID:11739466
RGD:4888511
NCBI chr14:113,805,616...113,820,445
Ensembl chr14:113,805,611...113,812,041
G
CYP19A2
cytochrome P450 19A2
ISO
mRNA, protein:decreased expresssion:ovary
RGD
PMID:23183180 PMID:23598873
RGD:7257717 RGD:7257726
NCBI chr 1:120,652,172...120,695,899
Ensembl chr 1:120,367,667...120,695,899
G
CYP19A3
cytochrome P450 19A3
susceptibility
ISO
DNA:missense mutation:cds:p.A264C (rs700519) (human) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:8265607 PMID:9177373 PMID:21262361 PMID:21282199 PMID:22381227
RGD:7257710
NCBI chr 1:120,476,890...120,556,103
Ensembl chr 1:120,367,667...120,695,899
G
CYP1A1
cytochrome P450 family 1 subfamily A member 1
ISO
RGD
PMID:18339256
RGD:11576309
NCBI chr 7:58,802,887...58,809,155
Ensembl chr 7:58,802,887...58,809,775
G
DACT3
dishevelled binding antagonist of beta catenin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:52,543,737...52,554,258
Ensembl chr 6:52,543,580...52,553,991
G
DCBLD2
discoidin, CUB and LCCL domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr13:160,063,742...160,160,054
Ensembl chr13:160,063,742...160,160,284
G
DDX54
DEAD-box helicase 54
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr14:38,650,660...38,668,266
Ensembl chr14:38,645,891...38,668,265
G
DLG4
discs large MAGUK scaffold protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr12:52,550,138...52,574,021
Ensembl chr12:52,550,141...52,575,143
G
DMD
dystrophin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr X:27,028,223...29,650,728
Ensembl chr X:27,028,231...28,383,840
G
ELAVL3
ELAV like RNA binding protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 2:70,114,475...70,134,348
Ensembl chr 2:70,117,060...70,134,348
G
EMSY
EMSY transcriptional repressor, BRCA2 interacting
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 9:10,628,053...10,715,814
Ensembl chr 9:10,628,053...10,716,396
G
ERRFI1
ERBB receptor feedback inhibitor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:68,667,651...68,682,629
Ensembl chr 6:68,669,153...68,682,623
G
FBXO44
F-box protein 44
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:71,747,210...71,754,519
Ensembl chr 6:71,743,261...71,774,223
G
FGF18
fibroblast growth factor 18
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr16:52,724,867...52,760,246
Ensembl chr16:52,725,356...52,759,791
G
FLT4
fms related receptor tyrosine kinase 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 2:78,076,008...78,115,137
Ensembl chr 2:78,076,080...78,115,126
G
FOXP3
forkhead box P3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr X:43,303,777...43,328,164
Ensembl chr X:43,303,785...43,322,968
G
FSHR
follicle stimulating hormone receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22885925
NCBI chr 3:91,607,236...91,775,255
Ensembl chr 3:91,607,305...91,774,683
G
FST
follistatin
ISO
DNA:polymorphism
RGD
PMID:10411917
RGD:1601259
NCBI chr16:32,806,341...32,811,382
Ensembl chr16:32,805,932...32,811,421
G
FUT7
fucosyltransferase 7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
G
GAB1
GRB2 associated binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 8:84,257,958...84,391,511
Ensembl chr 8:84,257,965...84,391,914
G
GDF9
growth differentiation factor 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22825968
NCBI chr 2:135,181,494...135,184,451
Ensembl chr 2:135,181,089...135,187,026
G
GIP
gastric inhibitory polypeptide
ISO
associated with Obesity; protein:increased expression:plasma (human)
RGD
PMID:19375579
RGD:2312588
NCBI chr12:25,160,783...25,167,952
Ensembl chr12:25,160,789...25,167,940
G
GNAS
GNAS complex locus
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr17:58,985,580...59,053,022
Ensembl chr17:58,998,981...59,053,021
G
GP1BB
glycoprotein Ib platelet subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr14:51,261,097...51,261,903
Ensembl chr14:51,260,963...51,262,114
G
GPX3
glutathione peroxidase 3
treatment
ISO
RGD
PMID:35663203
RGD:401827905
NCBI chr16:71,980,467...71,989,011
Ensembl chr16:71,980,475...71,989,026
G
HACD1
3-hydroxyacyl-CoA dehydratase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr10:43,901,590...43,929,441
Ensembl chr10:43,897,162...43,929,409
G
HELLS
helicase, lymphoid specific
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr14:105,923,727...105,967,003
Ensembl chr14:105,924,536...105,955,430
G
HMMR
hyaluronan mediated motility receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr16:60,290,684...60,332,411
Ensembl chr16:60,290,001...60,331,936
G
HOOK3
hook microtubule tethering protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr17:11,817,963...11,919,152
Ensembl chr17:11,818,031...11,923,196
G
HSD17B7
hydroxysteroid 17-beta dehydrogenase 7
ISO
mRNA:decreased expression:ovarian cortex (rat)
RGD
PMID:25887459
RGD:10402205
NCBI chr 4:87,720,747...87,743,037
Ensembl chr 4:87,720,118...87,742,992
G
HSD3B1
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1
ISO
CTD Direct Evidence: marker/mechanism protein:increased expression:ovary (rat)
CTD RGD
PMID:19698287 PMID:22381227
RGD:4145934
NCBI chr 4:101,565,229...101,574,110
G
IGF1
insulin like growth factor 1
ISO
protein:increased expression:serum:
RGD
PMID:15653207
RGD:8549491
NCBI chr 5:81,762,027...81,909,253
Ensembl chr 5:81,775,970...81,848,033
G
IL34
interleukin 34
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:13,588,748...13,679,864
Ensembl chr 6:13,588,787...13,659,895
G
INS
insulin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:2777199 PMID:11889176 PMID:16123091
NCBI chr 2:1,496,842...1,498,052
Ensembl chr 2:1,496,842...1,497,841
G
IQCC
IQ motif containing C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:88,682,922...88,685,797
Ensembl chr 6:88,683,119...88,685,796
G
ISYNA1
inositol-3-phosphate synthase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 2:59,363,672...59,367,003
Ensembl chr 2:59,363,716...59,367,002
G
JSRP1
junctional sarcoplasmic reticulum protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 2:76,418,508...76,422,405
Ensembl chr 2:76,418,320...76,422,263
G
KICS2
KICSTOR subunit 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 5:28,656,227...28,679,095
Ensembl chr 5:28,653,236...28,678,859
G
KRT3
keratin 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 5:18,075,881...18,082,119
Ensembl chr 5:18,075,864...18,082,196
G
LARP4
La ribonucleoprotein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 5:16,177,245...16,353,548
Ensembl chr 5:16,177,235...16,353,546
G
LEP
leptin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:22381227
NCBI chr18:20,106,867...20,124,071
Ensembl chr18:20,106,868...20,123,323
G
LHB
luteinizing hormone subunit beta
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:11889176 PMID:20378617
NCBI chr 6:54,263,574...54,269,286
Ensembl chr 6:54,263,576...54,271,086
G
LIF
LIF interleukin 6 family cytokine
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr14:47,221,540...47,239,513
Ensembl chr14:47,221,560...47,238,749
G
LMNA
lamin A/C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 4:93,899,019...93,927,255
Ensembl chr 4:93,899,019...93,926,320
G
LOC100624218
MORN repeat-containing protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:64,266,184...64,300,980
Ensembl chr 6:64,253,268...64,300,897
G
LOC102167255
leukemia inhibitory factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr16:23,627,700...23,672,724
Ensembl chr16:23,634,298...23,804,854
G
LPCAT2
lysophosphatidylcholine acyltransferase 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:29,999,504...30,056,858
Ensembl chr 6:29,998,488...30,056,862
G
LRATD1
LRAT domain containing 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 3:122,716,029...122,720,957
Ensembl chr 3:122,716,040...122,731,791
G
LSM5
LSM5 homolog, U6 small nuclear RNA and mRNA degradation associated
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr18:40,752,390...40,755,909
Ensembl chr18:40,752,461...40,755,906
G
LTK
leukocyte receptor tyrosine kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 1:129,863,837...129,867,254
G
MAD2L1
mitotic arrest deficient 2 like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 8:103,927,358...103,936,669
Ensembl chr 8:103,927,353...103,936,664
G
MANEA
mannosidase endo-alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 1:62,887,689...62,945,586
Ensembl chr 1:62,887,881...62,945,583
G
MAPK8IP3
mitogen-activated protein kinase 8 interacting protein 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 3:40,196,873...40,241,453
Ensembl chr 3:40,196,875...40,241,291
G
MAPRE3
microtubule associated protein RP/EB family member 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 3:112,084,467...112,136,079
Ensembl chr 3:112,084,469...112,136,061
G
MGAT5B
alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr12:4,655,374...4,730,098
Ensembl chr12:4,655,379...4,730,371
G
MIR222
microRNA mir-222
treatment
ISO
RNA:increased expression:blood
RGD
PMID:33230470
RGD:151893462
NCBI chr X:40,571,808...40,571,887
Ensembl chr X:40,571,808...40,571,887
G
MMP2
matrix metallopeptidase 2
ISO
protein:decreased expression:ovary
RGD
PMID:21910062
RGD:9999396
NCBI chr 6:30,059,247...30,087,031
Ensembl chr 6:30,058,595...30,086,982
G
MTNR1B
melatonin receptor 1B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:20207350
NCBI chr 9:25,556,756...25,557,792
Ensembl chr 9:25,545,390...25,558,054
G
MYBL1
MYB proto-oncogene like 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 4:68,120,078...68,159,513
Ensembl chr 4:68,119,865...68,159,509
G
NCOA2
nuclear receptor coactivator 2
ISO
RGD
PMID:29535146
RGD:152985548
NCBI chr 4:64,888,029...65,245,757
Ensembl chr 4:64,954,238...65,246,572
G
NCOA4
nuclear receptor coactivator 4
ISO
protein:increased expression:endometrium
RGD
PMID:16580389
RGD:2293533
NCBI chr14:90,505,614...90,531,302
Ensembl chr14:90,505,110...90,531,118
G
NCOR1
nuclear receptor corepressor 1
ISO
DNA:hypomethylation:promoter:g.218, 224 (rat)
RGD
PMID:22349439
RGD:5688285
NCBI chr12:59,256,868...59,392,564
Ensembl chr12:59,273,100...59,392,562
G
NGFR
nerve growth factor receptor
ISO
mRNA,protein:increased expression:ovary
RGD
PMID:15795180
RGD:5508374
NCBI chr12:25,699,410...25,720,355
Ensembl chr12:25,699,427...25,720,356
G
NMNAT3
nicotinamide nucleotide adenylyltransferase 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr13:80,431,405...80,556,808
Ensembl chr13:80,429,639...80,556,790
G
NOP53
NOP53 ribosome biogenesis factor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:53,443,453...53,451,707
Ensembl chr 6:53,443,385...53,452,017
G
NPB
neuropeptide B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr12:1,092,643...1,093,361
Ensembl chr12:1,092,653...1,093,202
G
NR3C1
nuclear receptor subfamily 3 group C member 1
ISO
mRNA:increased expression:ovary
RGD
PMID:22176470
RGD:7174741
NCBI chr 2:144,822,937...144,956,451
Ensembl chr 2:144,822,939...144,956,451
G
NR3C2
nuclear receptor subfamily 3 group C member 2
treatment
ISO
RGD
PMID:31925474
RGD:401976287
NCBI chr 8:80,303,172...80,669,050
Ensembl chr 8:80,312,234...80,668,412
G
NRG1
neuregulin 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr15:52,625,550...53,688,003
Ensembl chr15:52,630,679...52,839,505
G
PBK
PDZ binding kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr14:11,543,657...11,577,286
Ensembl chr14:11,543,603...11,566,702
G
PDE3B
phosphodiesterase 3B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 2:44,416,934...44,614,075
Ensembl chr 2:44,412,833...44,726,216
G
PDLIM4
PDZ and LIM domain 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 2:134,555,367...134,570,356
Ensembl chr 2:134,555,666...134,570,348
G
PECAM1
platelet and endothelial cell adhesion molecule 1
ISO
protein:increased expression:serum (human)
RGD
PMID:22456311
RGD:6767304
NCBI chr12:14,667,643...14,723,296
Ensembl chr12:14,649,044...14,723,293
G
PGR
progesterone receptor
ISO
protein:decreased expression:ovary:
RGD
PMID:19698287
RGD:4145934
NCBI chr 9:32,035,684...32,129,776
Ensembl chr 9:32,035,684...32,129,221
G
PLEKHG5
pleckstrin homology and RhoGEF domain containing G5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:67,316,818...67,373,787
Ensembl chr 6:67,321,534...67,362,838
G
PNPLA2
patatin like phospholipase domain containing 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 2:513,065...517,962
Ensembl chr 2:513,077...518,182
G
PRKD2
protein kinase D2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:52,559,066...52,599,174
Ensembl chr 6:52,559,393...52,599,132
G
PTAFR
platelet activating factor receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:85,235,390...85,272,360
Ensembl chr 6:85,235,394...85,261,760
G
PTCRA
pre T cell antigen receptor alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 7:38,006,074...38,012,193
Ensembl chr 7:38,006,050...38,012,193
G
PTGER3
prostaglandin E receptor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:141,958,955...142,160,437
Ensembl chr 6:141,958,955...142,161,286
G
PWWP2B
PWWP domain containing 2B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr14:140,635,806...140,657,675
Ensembl chr14:140,636,964...140,657,623
G
RAB2A
RAB2A, member RAS oncogene family
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 4:72,800,617...72,882,183
Ensembl chr 4:72,800,623...72,882,151
G
RACGAP1
Rac GTPase activating protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 5:15,894,314...15,943,619
Ensembl chr 5:15,904,712...15,943,609
G
RARRES2
retinoic acid receptor responder 2
treatment
ISO
RGD
PMID:24762064
RGD:15036823
NCBI chr18:55,903,693...55,906,976
Ensembl chr18:55,903,699...55,906,945
G
RASL10B
RAS like family 10 member B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr12:39,783,725...39,795,283
Ensembl chr12:39,783,729...39,795,069
G
RBP4
retinol binding protein 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:17456573
NCBI chr14:105,037,360...105,044,552
Ensembl chr14:105,037,464...105,044,765
G
REXO1
RNA exonuclease 1 homolog
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 2:76,694,269...76,719,026
Ensembl chr 2:76,693,796...76,718,394
G
RHPN1
rhophilin Rho GTPase binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 4:1,123,098...1,133,030
Ensembl chr 4:1,123,105...1,132,966
G
RP2
RP2 activator of ARL3 GTPase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr X:41,488,866...41,534,810
Ensembl chr X:41,488,626...41,534,799
G
RPL37A
ribosomal protein L37a
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr15:118,702,198...118,704,974
Ensembl chr15:118,702,325...118,706,909
G
RRM2
ribonucleotide reductase regulatory subunit M2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 3:126,357,198...126,367,145
Ensembl chr 3:126,347,819...126,365,644
G
RUNX3
RUNX family transcription factor 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:82,531,203...82,595,044
Ensembl chr 6:82,531,559...82,595,026
G
S100A7
S100 calcium binding protein A7
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 4:96,176,718...96,178,694
G
SAP30L
SAP30 like
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr16:68,695,892...68,709,952
Ensembl chr16:68,695,900...68,709,742
G
SCNN1A
sodium channel epithelial 1 subunit alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 5:64,287,529...64,312,917
Ensembl chr 5:64,285,015...64,313,612
G
SCT
secretin
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 2:382,783...385,082
Ensembl chr 2:383,799...384,841
G
SERPINE1
serpin family E member 1
ISO
protein:increased expression:plasma:
RGD
PMID:19375763
RGD:13208505
NCBI chr 3:8,863,738...8,871,572
Ensembl chr 3:8,863,695...8,871,547
G
SFTPC
surfactant protein C
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr14:6,440,309...6,443,104
Ensembl chr14:6,440,309...6,443,095
G
SLPI
secretory leukocyte peptidase inhibitor
ISO
protein:increased expression:ovary
RGD
PMID:21910062
RGD:9999396
NCBI chr17:47,595,804...47,598,364
Ensembl chr17:47,595,803...47,598,387
G
SOX15
SRY-box transcription factor 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr12:52,882,840...52,885,785
G
SPATA21
spermatogenesis associated 21
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:75,485,728...75,527,175
Ensembl chr 6:75,485,870...75,513,996
G
SPTBN4
spectrin beta, non-erythrocytic 4
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:48,729,839...48,812,799
Ensembl chr 6:48,729,419...48,812,796
G
SRD5A1
steroid 5 alpha-reductase 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543 PMID:22381227
NCBI chr16:75,309,830...75,335,438
Ensembl chr16:75,310,211...75,335,391
G
SRSF10
serine and arginine rich splicing factor 10
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:81,727,893...81,741,516
Ensembl chr 6:81,727,901...81,741,496
G
STAR
steroidogenic acute regulatory protein
ISO
protein:increased expression:ovary (rat) CTD Direct Evidence: marker/mechanism
RGD CTD
PMID:19698287 PMID:21262361
RGD:4145934
NCBI chr15:48,377,597...48,385,398
Ensembl chr15:48,377,521...48,385,462
G
TAB1
TGF-beta activated kinase 1 (MAP3K7) binding protein 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 5:8,827,363...8,852,814
Ensembl chr 5:8,826,840...8,852,776
G
TBX1
T-box transcription factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr14:51,289,376...51,297,110
Ensembl chr14:51,289,321...51,296,725
G
TCF15
transcription factor 15
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr17:34,626,682...34,632,881
Ensembl chr17:34,626,670...34,633,263
G
TEAD2
TEA domain transcription factor 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:54,448,183...54,462,325
Ensembl chr 6:54,448,191...54,462,210
G
TFRC
transferrin receptor
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr13:133,976,765...133,997,554
Ensembl chr13:133,970,985...134,000,276
G
TH
tyrosine hydroxylase
ISO
mRNA,protein:increased expression:ovary
RGD
PMID:15795180
RGD:5508374
NCBI chr 2:1,499,628...1,506,180
Ensembl chr 2:1,499,620...1,506,170
G
THAP3
THAP domain containing 3
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:67,452,272...67,463,400
Ensembl chr 6:67,455,277...67,463,399
G
TMEFF2
transmembrane protein with EGF like and two follistatin like domains 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr15:96,594,901...96,856,848
Ensembl chr15:96,594,970...96,855,743
G
TMEM151A
transmembrane protein 151A
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 2:6,090,535...6,095,499
Ensembl chr 2:6,090,543...6,095,352
G
TMEM151B
transmembrane protein 151B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 7:39,265,507...39,276,289
Ensembl chr 7:39,268,056...39,307,825
G
TMF1
TATA element modulatory factor 1
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr13:50,442,017...50,477,363
Ensembl chr13:50,444,256...50,477,291
G
TNFSF10
TNF superfamily member 10
ISO
protein:increased expression:ovary follicle, granulosa cell
RGD
PMID:17641850
RGD:2312746
NCBI chr13:111,021,952...111,103,060
Ensembl chr13:110,983,298...111,038,324
G
TNPO2
transportin 2
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 2:66,267,776...66,288,763
Ensembl chr 2:66,271,496...66,288,264
G
TNRC6B
trinucleotide repeat containing adaptor 6B
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 5:8,052,434...8,311,811
Ensembl chr 5:8,063,985...8,311,429
G
TONSL
tonsoku like, DNA repair protein
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 4:349,992...361,749
Ensembl chr 4:350,060...362,167
G
TOP2A
DNA topoisomerase II alpha
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr12:22,001,300...22,028,452
Ensembl chr12:22,001,282...22,028,450
G
TTK
TTK protein kinase
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 1:86,076,576...86,125,334
Ensembl chr 1:86,076,583...86,125,718
G
TTLL9
tubulin tyrosine ligase like 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr17:35,558,373...35,612,761
Ensembl chr17:35,558,525...35,609,033
G
UBE2H
ubiquitin conjugating enzyme E2 H
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr18:18,819,612...18,932,909
Ensembl chr18:18,819,641...18,932,904
G
VDR
vitamin D receptor
susceptibility
ISO
DNA:polymorphism,haplotype: :rs731236(human)
RGD
PMID:24078159
RGD:13210783
NCBI chr 5:78,205,807...78,266,505
Ensembl chr 5:78,205,810...78,266,475
G
VEGFA
vascular endothelial growth factor A
ISO
protein:increased expression:serum:
RGD
PMID:15653207
RGD:8549491
NCBI chr 7:38,746,393...38,762,282
Ensembl chr 7:38,746,052...38,761,366
G
ZMYM5
zinc finger MYM-type containing 5
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr11:576,721...630,607
Ensembl chr11:576,723...630,557
G
ZNF205
zinc finger protein 205
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 3:39,091,439...39,105,633
Ensembl chr 3:39,091,443...39,106,615
G
ZSWIM9
zinc finger SWIM-type containing 9
ISO
CTD Direct Evidence: marker/mechanism
CTD
PMID:21411543
NCBI chr 6:53,660,222...53,678,145
Ensembl chr 6:53,660,330...53,678,043
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all